Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

Why Is Rallybio (RLYB) Stock Up 93% Today?

Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.

3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition

Wall Street often ignores the stocks of companies with huge potential. Here are three overlooked stocks to buy. 

7 Top Stocks Under $7

Implementing an investment strategy of buying low-priced stocks may not be for everyone. But if you’re a growth-oriented investor who’s willing to accept a level…

If You Can Only Buy One Robotics Stock in April, It Better Be One of These 3 Names

Robotics stocks to buy like Symbotic, Intuitive Surgical and UiPath surge as AI integration reshapes industries from e-commerce to surgery.

3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild

Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape

With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access…

What Is Going on With Jaguar Health (JAGX) Stock Today?

A fifth reverse split may be coming to JAGX stock. Jaguar Health is seeking customers for its Crofelemer anti-diarrhea medicine.

Novartis Layoffs 2024: What to Know About the Latest NVS Job Cuts

Novartis layoffs will see the healthcare company cut 680 jobs in the U.S. and Switzerland over the next two to three years.

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024

Explore three penny stocks primed for significant growth, backed by Strong Buy ratings from Wall Street. Play it high-risk.

Billionaire Bargain Bin: 3 Stocks the Forbes 400 Loves (That You’ve Never Heard Of)

These Forbes 400 stocks have wealthy founders who run them with little fanfare or attention but are worth considering for your portfolio.

3 Cannabis Stocks on the Brink of a Massive Breakout

These cannabis stocks to buy offer legalization upside but include diversified revenue streams to shield your portfolio from instability.

Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027

Explore three stocks under $10 in electronic equipment and instruments, technology hardware, storage and peripherals, and biotechnology.

Thermo Fisher Layoffs 2024: What to Know About the Latest TMO Job Cuts

Thermo Fisher layoffs are in the news Tuesday after the company announced plans to cut 74 jobs at its plasmid manufacturing location.

April’s Hidden Gems: 3 Overlooked Stocks to Freshen Up Your Portfolio

Discover three overlooked stocks on Wall Street with the potential for growth and diversification this April.

Kenvue Layoffs 2024: What to Know About the Latest Neutrogena Job Cuts

Kenvue is cutting 135 jobs at Neutrogena. Here's what investors need to know about the Kenvue layoffs and why KVUE stock is still up.

The 5 Biggest Buyers of Tilray (TLRY) Stock

TLRY stock is falling lower after it reported a weak earnings report. Here are the top buyers of the cannabis company.

ACRV Stock Jumps 55% as Acrivon Therapeutics Gets $130 Million Boost

Acrivon Therapeutics stock is up on Tuesday with heavy trading of ACRV shares alongside $130 million in new funding today.

TLRY Stock Alert: Cannabis Legalization Hopes May Not Be Enough for Tilray

Tilray's beer business is growing faster than its pot business and is showing increased profits amid a cannabis cash slump

Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?

Vivos Therapeutics stock is up on Tuesday as VVOS investors react to the company securing full Medicare reimbursement for its OSA device.